0.3431
price down icon10.67%   -0.041
after-market Dopo l'orario di chiusura: .28 -0.0631 -18.39%
loading
Precedente Chiudi:
$0.3841
Aprire:
$0.332
Volume 24 ore:
14.12M
Relative Volume:
48.75
Capitalizzazione di mercato:
$13.94M
Reddito:
-
Utile/perdita netta:
$-52.53M
Rapporto P/E:
-0.0937
EPS:
-3.66
Flusso di cassa netto:
$-39.93M
1 W Prestazione:
-57.11%
1M Prestazione:
-50.94%
6M Prestazione:
-64.86%
1 anno Prestazione:
-74.20%
Intervallo 1D:
Value
$0.241
$0.4148
Intervallo di 1 settimana:
Value
$0.241
$0.828
Portata 52W:
Value
$0.241
$3.10

Unity Biotechnology Inc Stock (UBX) Company Profile

Name
Nome
Unity Biotechnology Inc
Name
Telefono
(650) 416-1192
Name
Indirizzo
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Name
Dipendente
16
Name
Cinguettio
@unitybiotech
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
UBX's Discussions on Twitter

Confronta UBX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
UBX
Unity Biotechnology Inc
0.3431 13.94M 0 -52.53M -39.93M -3.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-27 Downgrade H.C. Wainwright Buy → Neutral
2025-05-16 Downgrade Mizuho Outperform → Neutral
2024-08-22 Iniziato Rodman & Renshaw Buy
2023-11-16 Aggiornamento Wedbush Neutral → Outperform
2022-01-04 Aggiornamento ROTH Capital Neutral → Buy
2021-11-10 Aggiornamento Mizuho Neutral → Buy
2021-06-28 Aggiornamento Citigroup Sell → Buy
2021-06-07 Iniziato H.C. Wainwright Buy
2021-02-16 Downgrade Citigroup Neutral → Sell
2020-08-18 Downgrade Citigroup Buy → Neutral
2020-08-18 Downgrade Mizuho Buy → Neutral
2020-08-18 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-08-17 Downgrade ROTH Capital Buy → Neutral
2020-07-28 Iniziato ROTH Capital Buy
2019-12-12 Iniziato Cantor Fitzgerald Overweight
2019-03-07 Iniziato Cantor Fitzgerald Overweight
2018-09-07 Iniziato Mizuho Buy
2018-05-29 Iniziato Citigroup Buy
2018-05-29 Iniziato Goldman Neutral
2018-05-29 Iniziato Morgan Stanley Overweight
Mostra tutto

Unity Biotechnology Inc Borsa (UBX) Ultime notizie

pulisher
Jun 14, 2025

Biotech company once valued at $700 million slashes entire workforce - MSN

Jun 14, 2025
pulisher
Jun 12, 2025

Fierce Biotech Layoff Tracker 2025: ADC Tx lets go of 30% of workers; Vertex sheds 125 staffers - Fierce Biotech

Jun 12, 2025
pulisher
May 30, 2025

HC Wainwright Issues Optimistic Forecast for UBX Earnings - Defense World

May 30, 2025
pulisher
May 29, 2025

Unity Biotechnology stock hits 52-week low at $0.66 - Investing.com

May 29, 2025
pulisher
May 29, 2025

Unity Biotechnology stock hits 52-week low at $0.66 By Investing.com - Investing.com India

May 29, 2025
pulisher
May 28, 2025

HC Wainwright & Co. Downgrades Unity Biotechnology (LSE:0YC0) - Nasdaq

May 28, 2025
pulisher
May 28, 2025

Unity Biotechnology (NASDAQ:UBX) Receives Neutral Rating from HC Wainwright - Defense World

May 28, 2025
pulisher
May 27, 2025

Unity Biotech stock rating downgraded at H.C. Wainwright By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday - Benzinga

May 27, 2025
pulisher
May 27, 2025

Unity Biotechnology (UBX) Downgraded Amid Strategic Shifts | UBX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

HC Wainwright Downgrades Unity Biotechnology to Neutral From Buy, Adjusts Price Target to $2 From $4 - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Unity Biotechnology (UBX) Downgrade: HC Wainwright & Co. Cuts Pr - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Unity Biotech stock rating downgraded at H.C. Wainwright - Investing.com

May 27, 2025
pulisher
May 27, 2025

Unity Biotechnology (UBX) Downgrade: HC Wainwright & Co. Cuts Price Target | UBX Stock News - GuruFocus

May 27, 2025
pulisher
May 21, 2025

Jeff Bezos-backed, lifespan-focused Altos Labs buys small biotech with Stanford rootsSan Francisco Business Times - The Business Journals

May 21, 2025
pulisher
May 18, 2025

Unity Biotechnology (NASDAQ:UBX) Rating Lowered to “Neutral” at Mizuho - Defense World

May 18, 2025
pulisher
May 17, 2025

Mizuho cuts Unity Biotech stock rating, slashes price target to $1 - Investing.com Nigeria

May 17, 2025
pulisher
May 16, 2025

Mizuho Downgrades Unity Biotechnology to Neutral From Outperform After Diabetic Edema Treatment Misses Primary Endpoint, Cuts Price Target to $1 From $6 - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Unity Biotechnology (UBX) Downgraded Amid Trials and Strategic N - GuruFocus

May 16, 2025
pulisher
May 11, 2025

Unity Biotechnology (UBX) to Release Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 10, 2025

Bay Area biotech company Unity, once worth $700M, lays off entire remaining workforce - MSN

May 10, 2025
pulisher
May 09, 2025

'It's a mess out there': More biotech layoffs mean stiff competition for jobs at emerging companies - The Business Journals

May 09, 2025
pulisher
May 08, 2025

Renaissance Technologies LLC Sells 16,759 Shares of Unity Biotechnology, Inc. (NASDAQ:UBX) - Defense World

May 08, 2025
pulisher
May 07, 2025

Another Bay Area biotech company announces layoffs - MSN

May 07, 2025
pulisher
May 06, 2025

Bluebird pleads for deal support; Unity, Mersana lay off staff - BioPharma Dive

May 06, 2025
pulisher
May 05, 2025

Bay Area biotech company lays off every single worker, including CEO - SFGATE

May 05, 2025
pulisher
May 05, 2025

Finance Watch: Unity Lays Off All Employees As It Evaluates Alternatives - insights.citeline.com

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology (UBX) Reports Promising 36-Week Results from ASPIRE Trial | UBX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Unity Biotechnology Explores Strategic Alternatives Post-ASPIRE Study - TipRanks

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates - The Manila Times

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Announces Complete 36-Week Results from - GlobeNewswire

May 05, 2025
pulisher
May 05, 2025

UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of - Bluefield Daily Telegraph

May 05, 2025
pulisher
May 05, 2025

UNITY's New DME Treatment Rivals Aflibercept in Phase 2b Trial, Company Explores Strategic Options - Stock Titan

May 05, 2025
pulisher
May 01, 2025

UNITY Biotechnology to Present 36-Week Data from ASPIRE Phase 2B Study at ARVO 2025 Annual Meeting - Nasdaq

May 01, 2025
pulisher
May 01, 2025

UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting - The Manila Times

May 01, 2025
pulisher
Apr 29, 2025

UNITY Biotechnology tanks after failing to meet goal in eye disorder treatment trial - MSN

Apr 29, 2025
pulisher
Apr 28, 2025

Chardan Capital Brokers Decrease Earnings Estimates for UBX - Defense World

Apr 28, 2025
pulisher
Apr 26, 2025

Form 8-KCurrent report - ADVFN

Apr 26, 2025
pulisher
Apr 26, 2025

HC Wainwright Issues Positive Outlook for UBX Earnings - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

HC Wainwright Reiterates “Buy” Rating for Unity Biotechnology (NASDAQ:UBX) - Defense World

Apr 25, 2025
pulisher
Apr 25, 2025

Chardan Capital Reaffirms “Buy” Rating for Unity Biotechnology (NASDAQ:UBX) - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

Unity Biotechnology Reports Q1 2025 Financials and Study Updates - TipRanks

Apr 24, 2025
pulisher
Apr 23, 2025

H.C. Wainwright maintains $4 target on Unity Biotech stock - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Unity Biotechnology (UBX) Reports $16.9M in Cash, Prepares for F - GuruFocus

Apr 23, 2025

Unity Biotechnology Inc Azioni (UBX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):